#USA #Madrid #ArisGlobal #XDI Data Intelligence #NavaX Translation

A Major Leap in Life Sciences Technology by ArisGlobal

On February 11, 2026, during the prominent Breakthrough 2026 event held in Madrid, ArisGlobal, a leader in AI-first technology for life sciences, introduced a series of groundbreaking products aimed at revolutionizing data management and operational efficiency within the pharmaceutical industry. This announcement included the launch of XDI, a next-generation Data Intelligence cortex, alongside three new AI agents and the innovative NavaX Translation service.

Introducing XDI: The Future of Data Intelligence

XDI is designed to break down the silos in data management across various functions and systems in pharmaceutical research and development (R&D). Unlike traditional tools that only expedite individual workflow tasks, XDI offers a comprehensive, system-independent foundation that enhances the understanding and contextualization of data across the company. By doing so, it promotes coherent decision-making that is based on a unified interpretation, thus ensuring that all decisions in safety, regulation, clinical trials, quality, and manufacturing are grounded in a common understanding.

The platform's capability not only mitigates risks associated with varied interpretations but also fosters confidence in the operationalization of AI, making it a vital asset for companies aiming to scale their AI interactions effectively.

Expanding the NavaX Agents Suite

ArisGlobal has also enriched its NavaX Agents Suite with three powerful new AI agents, each catering to specific needs within regulatory intelligence and workflow management:

• - Intelligence Agents automatically interpret regulatory guidelines, converting them into precise checklists while assessing submissions in LifeSphere. This feature provides clarity with compliance assessments and establishes trust scores to improve submission quality.

• - Distribution Agents offer continuous compliance validation by frequently ingesting updated regulatory guidelines and validating them against internal distribution logic. This proactive approach activates workflow changes whenever discrepancies are identified, ensuring that operations stay aligned with regulatory standards.

• - Signals Agents serve as intelligent assistants capable of discerning user intents and determining optimal analytical approaches. They dynamically plan and execute workflows, enhancing collaboration across the safety, data, analysis, and expert judgment domains.

NavaX Translation: Redefining Data Reception Workflows

One of the most notable innovations, NavaX Translation, integrates certified translation capabilities directly into the data reception workflows, thanks to a strategic partnership with TransPerfect Life Sciences. This feature utilizes intelligent language detection to instantly route safety forms, not originally in English, for translation using industry-specific language models and specialized linguists. The seamless API integration returns translated forms back into LifeSphere, drastically reducing manual efforts involved in pharmacovigilance and accelerating processes from approximately five hours per case to under one minute.

Comments from Leadership

Aman Wasan, CEO of ArisGlobal, emphasized, "The challenge for life sciences is not just the adoption of AI but operationalizing it at scale with consistency and significant business impact. With these latest advancements, we empower organizations to transition from experimentation to production, relying AI as a robust foundation for decision-making."

Furthermore, Ann-Marie Orange, Chief Innovation Officer, highlighted the shift in technology's role for life science teams, stating, "These innovations represent a fundamental change from individual task automation toward orchestrating intelligence across entire operational ecosystems, leading to smarter decisions, faster insights, and truly scalable AI adoption."

The Bigger Picture: Breakthrough 2026

The Breakthrough 2026 event brings together industry executives, leaders, and experts to explore the theme of 'AI Operationalization.' The goal is to showcase how proven AI use cases are transitioning into everyday practices in life sciences, thus enhancing operational efficacy and decision-making standards.

For additional details on this transformative event and the newly launched products, visit ArisGlobal’s website or follow them on LinkedIn.

About ArisGlobal

ArisGlobal stands at the forefront of life sciences technology, offering cloud-based software solutions for pharmacovigilance, regulatory affairs, quality management, and medical affairs. LifeSphere®, the company’s unified product platform, integrates deep expertise, advanced technology, and analytical capabilities to help life sciences companies turn compliance into a strategic advantage. With over 300 clients, including leading pharmaceutical, biotech, and medical device companies worldwide, ArisGlobal is dedicated to driving innovation and excellence in the sector.